Associations between the polymorphisms of main components in PI3K/Akt pathway and risk of diabetic kidney disease: A meta‐analysis

伊诺斯 单核苷酸多态性 内科学 医学 荟萃分析 科克伦图书馆 等位基因 2型糖尿病 PI3K/AKT/mTOR通路 人口 肿瘤科 糖尿病 基因型 胃肠病学 内分泌学 生物信息学 生物 遗传学 细胞凋亡 一氧化氮合酶 基因 一氧化氮 环境卫生
作者
Hang Fu,Congcong Guo,Jing Zhang,Lusi Xu,Shengbing Jiang,Siyi Guo,Qiqi Sheng,Junyu Zhao,Lin Liao
标识
DOI:10.1002/iub.2711
摘要

Diabetic kidney disease (DKD) is a severe microvascular complication frequently associated with type 1 and type 2 diabetes mellitus. The objective of this work was to evaluate the relevance of PI3K/Akt pathway polymorphisms and DKD susceptibility by a meta-analysis.Case-control studies related to the relationship between PI3K/Akt pathway polymorphisms and DKD risk were searched from Pubmed, Embase, Cochrane Library, SINOMED, CNKI, and Wanfang databases. Statistical analysis and heterogeneity test were conducted by Review Manager 5.4.Totally, 52 eligible studies were enrolled, including seven single nucleotide polymorphisms (SNPs) for four genes in the PI3K/AKT pathway (GNB3: rs5443; eNOS: rs1799983, rs869109213, rs2070744; IL-6: rs1800795, rs1800796; TNFα: rs1800629). The "M" allele of eNOS rs1799983 was related to the increased risk of DKD under random effects model, especially in Asian population (Overall:M vs. W: I2 = 75%, OR = 1.29, 95%CI 1.07-1.56; MM + WM vs. WW: I2 = 75%, OR = 1.50, 95%CI 1.21-1.86). The "M" allele of eNOS rs869109213 was implicated with higher prevalence of DKD under random effects model, especially in Asian population (Overall:M vs. W: I2 = 63%, OR = 1.43, 95%CI 1.22-1.68; MM + WM vs. WW: I2 = 50%, OR = 1.36, 95%CI 1.16-1.58; MM vs. WM + WW: I2 = 59%, OR = 2.20, 95%CI 1.41-3.43). The "M" allele of eNOS rs2070744 was implicated with higher prevalence of DKD under random effects model, especially in Indian population (Overall: M vs. W: I2 = 47%, OR = 1.35, 95%CI 1.15-1.59; MM + WM vs. WW: I2 = 45%, OR = 1.32, 95%CI 1.07-1.62; MM vs. WM + WW: I2 = 65%, OR = 2.29, 95%CI 1.39-3.77). The "M" allele of IL-6 rs1800796 was predominately associated with higher DKD risks under random effects model, especially in Asian population (Overall: M versus W: I2 = 23%, OR = 1.49, 95%CI 1.21-1.84; MM + WM vs. WW: I2 = 1%, OR = 1.43, 95%CI 1.15-1.77; MM + WM vs. WW: I2 = 71%, OR = 2.77, 95%CI 1.09-7.06).This meta-analysis indicated that polymorphisms in the PI3K/Akt pathway in eNOS rs1799983, rs869109213, rs2070744, and IL-6 rs1800796 were related to the increased risk of DKD.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
superZ完成签到,获得积分10
刚刚
那个笨笨完成签到,获得积分10
刚刚
peike完成签到,获得积分10
2秒前
3秒前
小黄不慌完成签到,获得积分10
3秒前
闪闪的荔枝完成签到 ,获得积分10
5秒前
贾舒涵完成签到,获得积分10
5秒前
晶晶完成签到,获得积分10
5秒前
兴奋冷松完成签到,获得积分10
7秒前
何博完成签到,获得积分10
7秒前
LPPP发布了新的文献求助10
10秒前
坚强伯云完成签到,获得积分10
11秒前
fei完成签到 ,获得积分10
13秒前
夏之完成签到,获得积分10
13秒前
稳重的秋天完成签到,获得积分10
14秒前
14秒前
江边鸟完成签到 ,获得积分10
15秒前
wut完成签到,获得积分10
16秒前
上官聪展完成签到 ,获得积分10
17秒前
xxxksk完成签到 ,获得积分10
17秒前
巢周舟完成签到,获得积分10
18秒前
iuhgnor完成签到,获得积分0
19秒前
飘逸锦程完成签到 ,获得积分10
20秒前
wly完成签到,获得积分10
21秒前
王旭智完成签到 ,获得积分10
22秒前
李半斤完成签到,获得积分10
23秒前
MZ完成签到,获得积分10
23秒前
是我呀小夏完成签到 ,获得积分10
25秒前
25秒前
浮生若梦完成签到,获得积分10
26秒前
小二郎应助ruby采纳,获得10
26秒前
淡然水绿完成签到,获得积分10
27秒前
27秒前
shine完成签到,获得积分10
28秒前
anderson1738发布了新的文献求助10
30秒前
艾斯完成签到 ,获得积分10
30秒前
大方的飞风完成签到 ,获得积分10
30秒前
粱自中发布了新的文献求助10
30秒前
张光光完成签到 ,获得积分10
32秒前
xuening完成签到,获得积分10
33秒前
高分求助中
Contemporary Issues in Evaluating Treatment Outcomes in Neurodevelopmental Disorders 1000
rhetoric, logic and argumentation: a guide to student writers 1000
QMS18Ed2 | process management. 2nd ed 1000
One Man Talking: Selected Essays of Shao Xunmei, 1929–1939 1000
A Chronicle of Small Beer: The Memoirs of Nan Green 1000
From Rural China to the Ivy League: Reminiscences of Transformations in Modern Chinese History 900
Eric Dunning and the Sociology of Sport 850
热门求助领域 (近24小时)
化学 医学 材料科学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 免疫学 细胞生物学 电极
热门帖子
关注 科研通微信公众号,转发送积分 2916009
求助须知:如何正确求助?哪些是违规求助? 2556116
关于积分的说明 6912925
捐赠科研通 2216557
什么是DOI,文献DOI怎么找? 1178141
版权声明 588381
科研通“疑难数据库(出版商)”最低求助积分说明 576606